Vitamin K‐dependent gamma‐carboxyglutamic acid protein 1 promotes pancreatic ductal adenocarcinoma progression through stabilizing oncoprotein KRAS and tyrosine kinase receptor EGFR

Vitamin K‐dependent gamma‐carboxyglutamic acid protein 1 promotes pancreatic ductal adenocarcinoma progression through stabilizing oncoprotein KRAS and tyrosine kinase receptor EGFR

Abstract Background Vitamin K‐dependent γ‐glutamic acid carboxylation (Gla) proteins are calcium‐binding and membrane‐associated, participating in coagulation, bone turnover, and cancer biology. The molecular function of transmembrane proline‐rich Gla proteins (PRRGs) remains unexplored. Methods Ana...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zheng Wu, Qing Ye, Shan Zhang, Li‐Peng Hu, Xiao‐Qi Wang, Lin‐Li Yao, Lei Zhu, Shu‐Yu Xiao, Zong‐Hao Duan, Xue‐Li Zhang, Shu‐Heng Jiang, Zhi‐Gang Zhang, De‐Jun Liu, Dong‐Xue Li, Xiao‐Mei Yang
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Series:	Clinical and Translational Medicine
Subjects:	KRAS NEDD4 E3 ligases pancreatic cancer PRRG1 vitamin K‐dependent carboxylation
Online Access:	https://doi.org/10.1002/ctm2.70191
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

NEDD4 family E3 ligases in osteoporosis: mechanisms and emerging potential therapeutic targets
by: Heng Wu, et al.
Published: (2025-01-01)

Modulation of gut microbiota in targeted cancer therapy: insights on the EGFR/VEGF/KRAS pathways
by: Li Gong, et al.
Published: (2024-12-01)

The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy
by: Qinglong Ma, et al.
Published: (2025-01-01)

Brief Report: Not Created Equal: Survival Differences by KRAS Mutation Subtype in NSCLC Treated With Immunotherapy
by: Lova Sun, MD, MSCE, et al.
Published: (2025-01-01)

Targeting KRAS‐mutant pancreatic cancer through simultaneous inhibition of KRAS, MEK, and JAK2
by: Satoru Miyazaki, et al.
Published: (2025-02-01)

A Case of Non-Small Cell Lung Cancer with Mutually Exclusive <i>EGFR</i> and <i>KRAS</i> Mutations
by: Abhimanyu Tushir, et al.
Published: (2025-01-01)

Predictive Value of Initial 18F-FDG PET/CT for Identifying EGFR and KRAS Mutations in Patients with Non-small-cell Lung Cancer
by: Ozge Vural Topuz, et al.
Published: (2024-11-01)

The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta‐analysis
by: Wenli Xie, et al.
Published: (2019-03-01)

MVK, induced by Kras, represses cGAS-Sting signalling in lung adenocarcinoma
by: Changsheng Zhou, et al.
Published: (2025-01-01)

A Disentangled Representation-Based Multimodal Fusion Framework Integrating Pathomics and Radiomics for KRAS Mutation Detection in Colorectal Cancer
by: Zhilong Lv, et al.
Published: (2024-09-01)

The opposite association of HRAS and KRAS mutations with clinical variables of bladder cancer
by: M. P. Smal, et al.
Published: (2015-12-01)

Oncogenic mutant KRAS inhibition through oxidation at cysteine 118
by: Maximilian Kramer‐Drauberg, et al.
Published: (2025-02-01)

Effect of KRAS mutation status on clinicopathological characteristics and overall survival in patients with rectal cancer
by: Shengbin Zheng, et al.
Published: (2025-01-01)

The impact of KRAS mutations on the tumour microenvironment and treatment response in non-small cell lung cancer
by: Guomin Gu, et al.
Published: (2024-12-01)

Viral mimicry evasion: a new role for oncogenic KRAS mutations
by: Raymond Chen, et al.
Published: (2025-02-01)

Efficacy of first-line chemotherapy combined with immunotherapy or anti-angiogenic therapy in advanced KRAS-mutant non-small cell lung cancer
by: Huiping Qiang, et al.
Published: (2025-03-01)

KEAP1 mutations as key crucial prognostic biomarkers for resistance to KRAS-G12C inhibitors
by: Linyan Tian, et al.
Published: (2025-01-01)

Carnitine palmitoyltransferase 1C promotes EMT-associated cisplatin resistance in non-small cell lung cancer cells
by: Renjie Chen, et al.
Published: (2025-01-01)

Assessment of the quality of life in metastatic colorectal cancer patients with KRAS gene mutant: a case-control study
by: Fahmideh Bagrezaei, et al.
Published: (2025-01-01)

Machine Learning-Based Radiomics Analysis for Identifying KRAS Mutations in Non-Small-Cell Lung Cancer from CT Images: Challenges, Insights and Implications
by: Mirjam Schöneck, et al.
Published: (2025-01-01)

E3 ubiquitin ligase SYVN1 as a promising therapeutic target for diverse human diseases
by: Li Zhu, et al.
Published: (2025-02-01)

Proximal bronchiolar adenoma with malignant transformation to invasive mucinous adenocarcinoma with 4 years follow-up: a case report and literature review
by: Yuan-Hui Yang, et al.
Published: (2025-01-01)

Multi-omics mechanical analysis of gut microbiota, carboxylic acids, and cardiac gene expression interaction triggering diabetic cardiomyopathy
by: Meixin Shi, et al.
Published: (2025-01-01)

Transposon mediated functional genomic screening for BRAF inhibitor resistance reveals convergent Hippo and MAPK pathway activation events
by: Li Chen, et al.
Published: (2025-01-01)

Revealing the Mechanism of Protein Degradation in Postmortem Meat: The Role of Phosphorylation and Ubiquitination
by: Xinran Zhao, et al.
Published: (2025-01-01)

Novel Ethyl 1,5-Disubstituted-1H-Pyrazole-3-Carboxylates as a New Class of Antimicrobial Agents
by: Radwan Awwad A., et al.
Published: (2014-09-01)

<i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> Hot-Spot Mutations in Relation to Sidedness of Primary Colorectal Cancer: A Retrospective Cohort Study
by: Omer Abdelgadir, et al.
Published: (2025-01-01)

HDAC1-3 inhibition triggers NEDD4-mediated CCR2 downregulation and attenuates immunosuppression in myeloid-derived suppressor cells
by: Zhiqi Xie, et al.
Published: (2025-02-01)

Pancreatic Ductal Organoids React Kras Dependent to the Removal of Tumor Suppressive Roadblocks
by: Lukas Perkhofer, et al.
Published: (2019-01-01)

Research progress on the antiviral immune regulation of ubiquitin ligase F-box family
by: MENG Xiangbo, LI Tianqi, ZHANG Tong
Published: (2025-01-01)

NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model
by: Ismail M Meraz, et al.
Published: (2025-02-01)

Systematic Analysis of E3 Ligase-Related Genes Identified UBE2L3 as a Prognostic Biomarker Associated With Drug Resistance in Acute Myeloid Leukemia
by: Ling C, et al.
Published: (2025-01-01)

CUL4-Based Ubiquitin Ligases in Chromatin Regulation: An Evolutionary Perspective
by: Makiko Nakagawa, et al.
Published: (2025-01-01)

Clozapine-carboxylic acid plasticized co-amorphous dispersions: Preparation, characterization and solution stability evaluation
by: Ali Ahmed Mahmoud Abdelhaleem, et al.
Published: (2015-06-01)

Comparative bioavailability of two oral formulations of clopidogrel: Determination of clopidogrel and its carboxylic acid metabolite (SR26334) under fasting and fed conditions in healthy subjects
by: Brvar Nina, et al.
Published: (2014-03-01)

Sotorasib resistance triggers epithelial-mesenchymal transition and activates AKT and P38-mediated signaling
by: Raquel Arantes Megid, et al.
Published: (2025-01-01)

Remodeling of tumor microenvironments by EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer
by: Soomin Kim, et al.
Published: (2025-02-01)

The Arabidopsis RING‐Type E3 Ligase TEAR4 Controls Seed Germination by Targeting RGA for Degradation
by: Hao Yu, et al.
Published: (2025-01-01)

Ubiquitination Enzymes in Cancer, Cancer Immune Evasion, and Potential Therapeutic Opportunities
by: Aiman B. Awan, et al.
Published: (2025-01-01)

Up-flow anaerobic sludge blanket bioreactor for the production of carboxylates: effect of inocula on process performance and microbial communities
by: Adrián Lago, et al.
Published: (2025-01-01)